New investors Tencent and BGF joined by all existing major shareholders Funds will advance pipeline of novel TCR-CD3 bispecifics in cancer and autoimmune disease 13 November 2025; Cambridge, England – ...
Tahoe Therapeutics today announced the appointments of Wayne Spevak, Ph.D. as Vice President of Chemistry and Ben Powell, Ph.D. as Vice President of Drug Discovery, strengthening the company's ability ...
Enara’s discovery of DARKFOX delivers on the vision of translating the dark genome into a new class of clinically actionable Dark Antigens and ...
Vancouver, Canada, November 4th, 2025, FinanceWire Equity Insider News Commentary – The precision medicine sector reached ...
News Medical on MSN
Stress hormones silence key brain genes through chromatin-bound RNAs, study reveals
Priority Research Communication by Professor Yogesh Dwivedi and colleagues at the University of Alabama at Birmingham reports original, peer-reviewed findings demonstrating that long noncoding RNAs ...
Pharmacodynamic data further underscore clinical proof-of-mechanism for 'OR/NOT' Logic Gate, showing selective killing of leukemic blasts and leukemic stem cells (LSCs) while sparing healthy ...
Founded in 1896, DelVal has been cited by the National Society for Experiential Education as having the country’s top experiential learning program, by Princeton Review as one of the best colleges in ...
Preclinical data support best-in-class potential of masked T cell engager programs and platform utilizing Xilio’s ATACR and SEECR formats, ...
Operator: Ladies and gentlemen, thank you for joining us today. And third quarter 2025 results conference call. At this time, ...
"Ofirnoflast represents a first-in-class approach to modulating inflammasome ... ofirnoflast aims to restore immune balance and improve blood-cell production without broad immunosuppression.
Oxford University and Austrian researchers uncover a previously unknown ‘handbrake’ mechanism controlling how cells respond to cancer drugs, reshaping global understanding of cell metabolism and drug ...
Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the first quarter ended September 30, 2025.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback